ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SNG Synairgen Plc

4.65
0.00 (0.00%)
Last Updated: 10:52:51
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Synairgen Plc LSE:SNG London Ordinary Share GB00B0381Z20 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 4.65 4.52 4.99 - 172,565 10:52:51
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 0 -17.65M -0.0876 -0.53 9.36M
Synairgen Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker SNG. The last closing price for Synairgen was 4.65p. Over the last year, Synairgen shares have traded in a share price range of 3.65p to 10.62p.

Synairgen currently has 201,374,975 shares in issue. The market capitalisation of Synairgen is £9.36 million. Synairgen has a price to earnings ratio (PE ratio) of -0.53.

Synairgen Share Discussion Threads

Showing 18701 to 18724 of 99175 messages
Chat Pages: Latest  751  750  749  748  747  746  745  744  743  742  741  740  Older
DateSubjectAuthorDiscuss
29/7/2020
16:17
DNL EXPLODINGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG

DNL = 3x Approvals expected during next 2 months including an Orphan Drug with FDA decision on September 29 = CHEAPEST UK Biotech a potential 500%++ GEM


Market Cap £45 million
Cash £15 million or Cash untill early 2022
Price 48p


Alkindi approval in Australia expected this Quarter
Alkindi approval in Israel expected this Quarter
FDA decision for Alkindi on September 29
EMA Decision for Chronocort expected in early Q1 2021
US-Partnership for Chronocort (Phase3 ready) in 2H 2020

ih_752952
29/7/2020
16:08
O/t - VAL worth a good look imo.A very good q&A on the website. Anwers lots of questions and am confident in Dr Dilly. Already reduced annual staff remuneration from GBP 900k to about GBP 300kRight now market cap is just GBP 4m with over GBP 2m of cash.
jungmana
29/7/2020
15:46
Broker said 360p but with approval no upper limit!!!!!That says all we need to know!
dave444
29/7/2020
15:41
Price has held well over recent sessions. Waiting for development. Anybody's guess where it could go from here on good progress.
allin
29/7/2020
15:40
Very high.

Just IMHO of course....

nobbygnome
29/7/2020
15:39
Nobby...whats your opinion on the chances of SNG001 being granted a special licence to allow the public to be treated without having to wait for a large phase 3 study?
kop202
29/7/2020
15:24
That expert opinion contains some good analysis....and some appalling uninformed comment. The wide difference in the views from these so callled experts shows that you will get as many views as experts you ask. All that matters is what the regulators say....
nobbygnome
29/7/2020
15:10
no doubt walked down for an order filling, another TR1? News must be so close on peer review, approval or deal or COPD results.
jambam
29/7/2020
15:08
Thanks for the link.
eggy toast
29/7/2020
15:04
Very interesting that they will take my entire holding (well over £100k) in one go well above bid....think we will see this move significantly higher by the weekend.
oranolio
Chat Pages: Latest  751  750  749  748  747  746  745  744  743  742  741  740  Older

Your Recent History

Delayed Upgrade Clock